nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.532	0.591	CbGaD
Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.368	0.409	CbGaD
Prochlorperazine—DRD3—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00563	0.0687	CbGpPWpGaD
Prochlorperazine—DRD3—Dopamine receptors—DRD2—Gilles de la Tourette syndrome	0.00524	0.064	CbGpPWpGaD
Prochlorperazine—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00444	0.0541	CbGpPWpGaD
Prochlorperazine—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00431	0.0526	CbGpPWpGaD
Prochlorperazine—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00179	0.0218	CbGpPWpGaD
Prochlorperazine—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.00166	0.0203	CbGpPWpGaD
Prochlorperazine—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00158	0.0193	CbGpPWpGaD
Prochlorperazine—DRD3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0015	0.0183	CbGpPWpGaD
Prochlorperazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00141	0.0172	CbGpPWpGaD
Prochlorperazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00137	0.0167	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0013	0.0159	CbGpPWpGaD
Prochlorperazine—DRD3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00124	0.0152	CbGpPWpGaD
Prochlorperazine—DRD3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00116	0.0141	CbGpPWpGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00115	0.014	CbGpPWpGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00113	0.0138	CbGpPWpGaD
Prochlorperazine—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00111	0.0136	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00111	0.0136	CbGpPWpGaD
Prochlorperazine—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00108	0.0132	CbGpPWpGaD
Prochlorperazine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00105	0.0128	CbGpPWpGaD
Prochlorperazine—DRD3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00105	0.0128	CbGpPWpGaD
Prochlorperazine—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.001	0.0123	CbGpPWpGaD
Prochlorperazine—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00098	0.012	CbGpPWpGaD
Prochlorperazine—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.000975	0.0119	CbGpPWpGaD
Prochlorperazine—DRD3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000974	0.0119	CbGpPWpGaD
Prochlorperazine—HRH1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000962	0.0117	CbGpPWpGaD
Prochlorperazine—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000952	0.0116	CbGpPWpGaD
Prochlorperazine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000947	0.0116	CbGpPWpGaD
Prochlorperazine—HRH1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000934	0.0114	CbGpPWpGaD
Prochlorperazine—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000934	0.0114	CbGpPWpGaD
Prochlorperazine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000919	0.0112	CbGpPWpGaD
Prochlorperazine—DRD3—nervous system—Gilles de la Tourette syndrome	0.00091	0.0973	CbGeAlD
Prochlorperazine—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000906	0.0111	CbGpPWpGaD
Prochlorperazine—DRD3—central nervous system—Gilles de la Tourette syndrome	0.000876	0.0937	CbGeAlD
Prochlorperazine—HRH1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00087	0.0106	CbGpPWpGaD
Prochlorperazine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000856	0.0105	CbGpPWpGaD
Prochlorperazine—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000844	0.0103	CbGpPWpGaD
Prochlorperazine—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000824	0.0101	CbGpPWpGaD
Prochlorperazine—DRD3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000811	0.0099	CbGpPWpGaD
Prochlorperazine—HRH1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000809	0.00987	CbGpPWpGaD
Prochlorperazine—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0008	0.00976	CbGpPWpGaD
Prochlorperazine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000796	0.00972	CbGpPWpGaD
Prochlorperazine—HRH1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000785	0.00959	CbGpPWpGaD
Prochlorperazine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000773	0.00943	CbGpPWpGaD
Prochlorperazine—HRH1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000732	0.00893	CbGpPWpGaD
Prochlorperazine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00072	0.00879	CbGpPWpGaD
Prochlorperazine—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000703	0.00859	CbGpPWpGaD
Prochlorperazine—DRD3—brain—Gilles de la Tourette syndrome	0.000696	0.0744	CbGeAlD
Prochlorperazine—DRD3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000682	0.00833	CbGpPWpGaD
Prochlorperazine—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000621	0.00758	CbGpPWpGaD
Prochlorperazine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000616	0.0659	CbGeAlD
Prochlorperazine—HRH1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00061	0.00744	CbGpPWpGaD
Prochlorperazine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0006	0.00732	CbGpPWpGaD
Prochlorperazine—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000591	0.00722	CbGpPWpGaD
Prochlorperazine—DRD3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000552	0.00674	CbGpPWpGaD
Prochlorperazine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000525	0.0562	CbGeAlD
Prochlorperazine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000522	0.00637	CbGpPWpGaD
Prochlorperazine—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000512	0.00625	CbGpPWpGaD
Prochlorperazine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000506	0.0541	CbGeAlD
Prochlorperazine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000506	0.0541	CbGeAlD
Prochlorperazine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000504	0.00615	CbGpPWpGaD
Prochlorperazine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000488	0.0521	CbGeAlD
Prochlorperazine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000468	0.0501	CbGeAlD
Prochlorperazine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000421	0.00513	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000408	0.00498	CbGpPWpGaD
Prochlorperazine—CHRM2—brain—Gilles de la Tourette syndrome	0.000402	0.0429	CbGeAlD
Prochlorperazine—HTR2C—brain—Gilles de la Tourette syndrome	0.000387	0.0414	CbGeAlD
Prochlorperazine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000385	0.0412	CbGeAlD
Prochlorperazine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000371	0.0396	CbGeAlD
Prochlorperazine—DRD3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00036	0.0044	CbGpPWpGaD
Prochlorperazine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000304	0.0325	CbGeAlD
Prochlorperazine—DRD2—brain—Gilles de la Tourette syndrome	0.000294	0.0315	CbGeAlD
Prochlorperazine—DRD3—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000293	0.00358	CbGpPWpGaD
Prochlorperazine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000293	0.0313	CbGeAlD
Prochlorperazine—DRD3—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000273	0.00333	CbGpPWpGaD
Prochlorperazine—Domperidone—DRD3—Gilles de la Tourette syndrome	0.000268	0.0293	CrCbGaD
Prochlorperazine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000266	0.00325	CbGpPWpGaD
Prochlorperazine—DRD3—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000259	0.00316	CbGpPWpGaD
Prochlorperazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000245	0.0267	CrCbGaD
Prochlorperazine—DRD3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000241	0.00294	CbGpPWpGaD
Prochlorperazine—Aripiprazole—DRD4—Gilles de la Tourette syndrome	0.00024	0.0262	CrCbGaD
Prochlorperazine—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00024	0.00293	CbGpPWpGaD
Prochlorperazine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000235	0.0251	CbGeAlD
Prochlorperazine—HRH1—brain—Gilles de la Tourette syndrome	0.000232	0.0249	CbGeAlD
Prochlorperazine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000231	0.0247	CbGeAlD
Prochlorperazine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000231	0.00282	CbGpPWpGaD
Prochlorperazine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000226	0.0242	CbGeAlD
Prochlorperazine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000224	0.00274	CbGpPWpGaD
Prochlorperazine—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000224	0.00273	CbGpPWpGaD
Prochlorperazine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000223	0.0238	CbGeAlD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000214	0.00262	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000208	0.00254	CbGpPWpGaD
Prochlorperazine—Nefazodone—SLC6A3—Gilles de la Tourette syndrome	0.000207	0.0226	CrCbGaD
Prochlorperazine—Aripiprazole—DRD3—Gilles de la Tourette syndrome	0.000207	0.0226	CrCbGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000206	0.00251	CbGpPWpGaD
Prochlorperazine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000204	0.00249	CbGpPWpGaD
Prochlorperazine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000198	0.00242	CbGpPWpGaD
Prochlorperazine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000197	0.0024	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000194	0.00237	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000192	0.00234	CbGpPWpGaD
Prochlorperazine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000191	0.00233	CbGpPWpGaD
Prochlorperazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.000191	0.0208	CrCbGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000189	0.00231	CbGpPWpGaD
Prochlorperazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000186	0.0203	CrCbGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000186	0.00227	CbGpPWpGaD
Prochlorperazine—Domperidone—DRD2—Gilles de la Tourette syndrome	0.000186	0.0203	CrCbGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000184	0.00224	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000184	0.00224	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000183	0.00223	CbGpPWpGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00018	0.0022	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000178	0.00218	CbGpPWpGaD
Prochlorperazine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000178	0.00217	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000177	0.00217	CbGpPWpGaD
Prochlorperazine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000177	0.0189	CbGeAlD
Prochlorperazine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000176	0.00214	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000173	0.00211	CbGpPWpGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000168	0.00205	CbGpPWpGaD
Prochlorperazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000167	0.0182	CrCbGaD
Prochlorperazine—Mianserin—DRD3—Gilles de la Tourette syndrome	0.000167	0.0182	CrCbGaD
Prochlorperazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000167	0.0182	CrCbGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000166	0.00203	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000165	0.00202	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000162	0.00198	CbGpPWpGaD
Prochlorperazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000159	0.0174	CrCbGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000159	0.00194	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000157	0.00192	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000157	0.00192	CbGpPWpGaD
Prochlorperazine—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000157	0.00191	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000157	0.00191	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000157	0.00191	CbGpPWpGaD
Prochlorperazine—Mianserin—SLC6A3—Gilles de la Tourette syndrome	0.000155	0.0169	CrCbGaD
Prochlorperazine—Zuclopenthixol—DRD2—Gilles de la Tourette syndrome	0.000155	0.0169	CrCbGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000154	0.00189	CbGpPWpGaD
Prochlorperazine—Loxapine—DRD4—Gilles de la Tourette syndrome	0.000154	0.0168	CrCbGaD
Prochlorperazine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000152	0.00186	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000152	0.00186	CbGpPWpGaD
Prochlorperazine—Chlorprothixene—DRD3—Gilles de la Tourette syndrome	0.000152	0.0166	CrCbGaD
Prochlorperazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.00015	0.0164	CrCbGaD
Prochlorperazine—Quetiapine—DRD4—Gilles de la Tourette syndrome	0.00015	0.0164	CrCbGaD
Prochlorperazine—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000146	0.00178	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000144	0.00176	CbGpPWpGaD
Prochlorperazine—Aripiprazole—DRD2—Gilles de la Tourette syndrome	0.000143	0.0156	CrCbGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000142	0.00173	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00014	0.00171	CbGpPWpGaD
Prochlorperazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000139	0.0152	CrCbGaD
Prochlorperazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000138	0.0151	CrCbGaD
Prochlorperazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000137	0.015	CrCbGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000136	0.00166	CbGpPWpGaD
Prochlorperazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000136	0.0148	CrCbGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000136	0.00166	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000136	0.00166	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000134	0.00164	CbGpPWpGaD
Prochlorperazine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.000134	0.0146	CrCbGaD
Prochlorperazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000134	0.0146	CrCbGaD
Prochlorperazine—Loxapine—DRD3—Gilles de la Tourette syndrome	0.000133	0.0145	CrCbGaD
Prochlorperazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.000132	0.0144	CrCbGaD
Prochlorperazine—Quetiapine—DRD3—Gilles de la Tourette syndrome	0.000129	0.0141	CrCbGaD
Prochlorperazine—Clozapine—DRD4—Gilles de la Tourette syndrome	0.000129	0.0141	CrCbGaD
Prochlorperazine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000126	0.00154	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000123	0.00151	CbGpPWpGaD
Prochlorperazine—Loxapine—SLC6A3—Gilles de la Tourette syndrome	0.000123	0.0135	CrCbGaD
Prochlorperazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000121	0.0132	CrCbGaD
Prochlorperazine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000121	0.00148	CbGpPWpGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00012	0.00146	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00012	0.00146	CbGpPWpGaD
Prochlorperazine—Zuclopenthixol—HTR2A—Gilles de la Tourette syndrome	0.00012	0.0131	CrCbGaD
Prochlorperazine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000119	0.00146	CbGpPWpGaD
Prochlorperazine—Nefazodone—HTR2A—Gilles de la Tourette syndrome	0.000119	0.013	CrCbGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000118	0.00144	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000118	0.00144	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000116	0.00142	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000116	0.00141	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000116	0.00141	CbGpPWpGaD
Prochlorperazine—Mianserin—DRD2—Gilles de la Tourette syndrome	0.000115	0.0126	CrCbGaD
Prochlorperazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000115	0.0126	CrCbGaD
Prochlorperazine—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000114	0.0125	CrCbGaD
Prochlorperazine—Clozapine—DRD3—Gilles de la Tourette syndrome	0.000111	0.0121	CrCbGaD
Prochlorperazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000111	0.0121	CrCbGaD
Prochlorperazine—Aripiprazole—HTR2A—Gilles de la Tourette syndrome	0.000111	0.0121	CrCbGaD
Prochlorperazine—Trazodone—HTR2A—Gilles de la Tourette syndrome	0.00011	0.012	CrCbGaD
Prochlorperazine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00011	0.00134	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000108	0.00132	CbGpPWpGaD
Prochlorperazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000107	0.0117	CrCbGaD
Prochlorperazine—Chlorprothixene—DRD2—Gilles de la Tourette syndrome	0.000105	0.0115	CrCbGaD
Prochlorperazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000105	0.0115	CrCbGaD
Prochlorperazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000105	0.0114	CrCbGaD
Prochlorperazine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.000103	0.0113	CrCbGaD
Prochlorperazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000103	0.0113	CrCbGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000103	0.00125	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000102	0.00125	CbGpPWpGaD
Prochlorperazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.000102	0.0111	CrCbGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000101	0.00123	CbGpPWpGaD
Prochlorperazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	9.95e-05	0.0109	CrCbGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.92e-05	0.00121	CbGpPWpGaD
Prochlorperazine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	9.69e-05	0.0106	CrCbGaD
Prochlorperazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	9.5e-05	0.0104	CrCbGaD
Prochlorperazine—Promethazine—DRD2—Gilles de la Tourette syndrome	9.36e-05	0.0102	CrCbGaD
Prochlorperazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	9.23e-05	0.0101	CrCbGaD
Prochlorperazine—Loxapine—DRD2—Gilles de la Tourette syndrome	9.17e-05	0.01	CrCbGaD
Prochlorperazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	9.13e-05	0.00997	CrCbGaD
Prochlorperazine—Quetiapine—DRD2—Gilles de la Tourette syndrome	8.95e-05	0.00977	CrCbGaD
Prochlorperazine—Mianserin—HTR2A—Gilles de la Tourette syndrome	8.92e-05	0.00974	CrCbGaD
Prochlorperazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	8.92e-05	0.00974	CrCbGaD
Prochlorperazine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.86e-05	0.00108	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.85e-05	0.00108	CbGpPWpGaD
Prochlorperazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	8.58e-05	0.00937	CrCbGaD
Prochlorperazine—Desipramine—DRD2—Gilles de la Tourette syndrome	8.5e-05	0.00927	CrCbGaD
Prochlorperazine—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.24e-05	0.00101	CbGpPWpGaD
Prochlorperazine—Promazine—DRD2—Gilles de la Tourette syndrome	8.23e-05	0.00898	CrCbGaD
Prochlorperazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	8.16e-05	0.00891	CrCbGaD
Prochlorperazine—Chlorprothixene—HTR2A—Gilles de la Tourette syndrome	8.13e-05	0.00887	CrCbGaD
Prochlorperazine—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.03e-05	0.000981	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.9e-05	0.000965	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.82e-05	0.000954	CbGpPWpGaD
Prochlorperazine—Clozapine—DRD2—Gilles de la Tourette syndrome	7.7e-05	0.00841	CrCbGaD
Prochlorperazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	7.69e-05	0.00839	CrCbGaD
Prochlorperazine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.67e-05	0.000937	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.67e-05	0.000936	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.55e-05	0.000922	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.49e-05	0.000914	CbGpPWpGaD
Prochlorperazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	7.34e-05	0.00801	CrCbGaD
Prochlorperazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	7.24e-05	0.00791	CrCbGaD
Prochlorperazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	7.23e-05	0.00789	CrCbGaD
Prochlorperazine—Imipramine—DRD2—Gilles de la Tourette syndrome	7.21e-05	0.00787	CrCbGaD
Prochlorperazine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.18e-05	0.000876	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.15e-05	0.000872	CbGpPWpGaD
Prochlorperazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	7.13e-05	0.00779	CrCbGaD
Prochlorperazine—Loxapine—HTR2A—Gilles de la Tourette syndrome	7.09e-05	0.00774	CrCbGaD
Prochlorperazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	7.06e-05	0.0077	CrCbGaD
Prochlorperazine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.97e-05	0.000851	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.97e-05	0.00085	CbGpPWpGaD
Prochlorperazine—Quetiapine—HTR2A—Gilles de la Tourette syndrome	6.92e-05	0.00755	CrCbGaD
Prochlorperazine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	6.9e-05	0.000843	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.85e-05	0.000836	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.77e-05	0.000826	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.74e-05	0.000822	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.65e-05	0.000811	CbGpPWpGaD
Prochlorperazine—Desipramine—HTR2A—Gilles de la Tourette syndrome	6.57e-05	0.00717	CrCbGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.54e-05	0.000798	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.49e-05	0.000792	CbGpPWpGaD
Prochlorperazine—Promazine—HTR2A—Gilles de la Tourette syndrome	6.36e-05	0.00694	CrCbGaD
Prochlorperazine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.33e-05	0.000773	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.22e-05	0.000759	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.19e-05	0.000756	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.15e-05	0.000751	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.12e-05	0.000747	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.09e-05	0.000744	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.04e-05	0.000737	CbGpPWpGaD
Prochlorperazine—Clozapine—HTR2A—Gilles de la Tourette syndrome	5.95e-05	0.0065	CrCbGaD
Prochlorperazine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.94e-05	0.000725	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.77e-05	0.000705	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.62e-05	0.000686	CbGpPWpGaD
Prochlorperazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	5.6e-05	0.00611	CrCbGaD
Prochlorperazine—Imipramine—HTR2A—Gilles de la Tourette syndrome	5.57e-05	0.00608	CrCbGaD
Prochlorperazine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.53e-05	0.000675	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.24e-05	0.00064	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.01e-05	0.000611	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.75e-05	0.000579	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.55e-05	0.000555	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	4.51e-05	0.000551	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.42e-05	0.00054	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.42e-05	0.000539	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.34e-05	0.000529	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.27e-05	0.000521	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.24e-05	0.000517	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.12e-05	0.000502	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.01e-05	0.00049	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.94e-05	0.000481	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.88e-05	0.000473	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.83e-05	0.000468	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.74e-05	0.000457	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.67e-05	0.000448	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.63e-05	0.000443	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.61e-05	0.000441	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.57e-05	0.000435	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.51e-05	0.000428	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.32e-05	0.000406	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.27e-05	0.000399	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.1e-05	0.000378	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.69e-05	0.000328	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.37e-05	0.000289	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000284	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.000279	CbGpPWpGaD
